Suppr超能文献

伊朗西部和西北部结核病患者的耐药模式

Patterns of Drug Resistance Among Tuberculosis Patients in West and Northwestern Iran.

作者信息

Sahebi Leyla, Ansarin Khalil, Mohajeri Parviz, Khalili Majid, Monfaredan Amir, Farajnia Safar, Zadeh Simin Khayyat

机构信息

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Science. Tabriz, Iran.

Microbiology Department, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.

出版信息

Open Respir Med J. 2016 Jun 30;10:29-35. doi: 10.2174/1874306401610010029. eCollection 2016.

Abstract

BACKGROUND

Tuberculosis (TB) is the leading cause of morbidity and mortality among chronic infectious diseases.

OBJECTIVE

The goal of this cross-sectional study (2011-2013;2013) was to examine the patterns of TB drug resistance among HIV-negative pulmonary TB patients in regions near the Iranian border.

METHOD

To this end, MTB isolates were harvested from 300 HIV-negative, pulmonary smear-positive TB patients from the northwest and west Iranian border provinces. Isolates were subjected to first and second-line drug susceptibility testing by the 1% proportion method. Demographic and clinical data were provided using a questionnaire and information from patient records. Results were analyzed using SPSS-18.

RESULTS

The mean age of the patients was 52.03 years and 54.3% were male. The prevalence of resistance to any TB drug was 13.6% (38 cases). Eleven percent of the new treatment TB group (28 patients) and 40.7% of the retreatment TB group (11 patients) were resistant to all TB drugs. Twelve (4.3%) patients had multidrug-resistant tuberculosis (MDR-TB) (2.38% in the new TB treatment group and 23.1% in the retreatment group). One patient had extensively drug-resistant tuberculosis (XDR-TB). There was a statistically significant relationship between TB drug resistance and smoking (p=0.02) and a history of migration from village to city (p=0.04), also between TB drug resistance and recurrence of TB in patients that had previously received treatment (p<0.001).

CONCLUSION

Knowledge of drug resistance patterns for new and previously treated cases is critical for effective control of MDR-TB in different regions of the country. The burden of MDR-TB in retreatment cases was high. Previous TB treatment was one of the most important mokers and those who had a history of rural to urban migration were at high risk for the occurrence of TB drug resistance.

摘要

背景

结核病是慢性传染病中发病和死亡的主要原因。

目的

这项横断面研究(2011 - 2013年;2013年)的目的是调查伊朗边境附近地区HIV阴性肺结核患者的结核耐药模式。

方法

为此,从伊朗西北部和西部边境省份的300例HIV阴性、痰涂片阳性肺结核患者中采集结核分枝杆菌分离株。采用1%比例法对分离株进行一线和二线药物敏感性检测。通过问卷调查和患者病历信息提供人口统计学和临床数据。使用SPSS - 18进行结果分析。

结果

患者的平均年龄为52.03岁,54.3%为男性。对任何一种抗结核药物耐药的患病率为13.6%(38例)。新治疗肺结核组的11%(28例患者)和复治肺结核组的40.7%(11例患者)对所有抗结核药物耐药。12例(4.3%)患者患有耐多药结核病(MDR - TB)(新肺结核治疗组为2.38%,复治组为23.1%)。1例患者患有广泛耐药结核病(XDR - TB)。结核耐药与吸烟(p = 0.02)、从农村迁移到城市的病史(p = 0.04)之间存在统计学显著关系,在既往接受过治疗的患者中,结核耐药与结核病复发之间也存在统计学显著关系(p < 0.001)。

结论

了解新发病例和既往治疗病例的耐药模式对于有效控制该国不同地区的耐多药结核病至关重要。复治病例中耐多药结核病的负担较高。既往结核病治疗是最重要的危险因素之一,有从农村到城市迁移病史的人发生结核耐药的风险较高。

相似文献

1
Patterns of Drug Resistance Among Tuberculosis Patients in West and Northwestern Iran.
Open Respir Med J. 2016 Jun 30;10:29-35. doi: 10.2174/1874306401610010029. eCollection 2016.
2
Beijing strains of in smear-positive tuberculosis patients in North-West and West of Iran.
Adv Biomed Res. 2016 Nov 28;5:181. doi: 10.4103/2277-9175.190982. eCollection 2016.
4
Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran.
Asian Pac J Trop Med. 2014 Mar;7(3):193-6. doi: 10.1016/S1995-7645(14)60019-5.
5
Epidemiology and patterns of drug resistance among tuberculosis patients in Northwestern Iran.
Indian J Med Microbiol. 2016 Jul-Sep;34(3):362-8. doi: 10.4103/0255-0857.188352.
7
The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
PLoS One. 2020 Feb 13;15(2):e0229040. doi: 10.1371/journal.pone.0229040. eCollection 2020.
8
Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
Int J Tuberc Lung Dis. 2017 Mar 1;21(3):303-308. doi: 10.5588/ijtld.16.0444.
10
Drug Resistance Characteristics of Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China.
Front Cell Infect Microbiol. 2019 Nov 5;9:345. doi: 10.3389/fcimb.2019.00345. eCollection 2019.

引用本文的文献

2
Epidemiology of first- and second-line drugs-resistant pulmonary tuberculosis in Iran: Systematic review and meta-analysis.
J Clin Tuberc Other Mycobact Dis. 2024 Mar 16;35:100430. doi: 10.1016/j.jctube.2024.100430. eCollection 2024 May.
3
Pattern of drug resistant in the west and northwest of Iran: a meta-analysis.
Iran J Microbiol. 2022 Jun;14(3):285-290. doi: 10.18502/ijm.v14i3.9754.
4
Rifampicin-resistant tuberculosis in Iran: A systematic review and meta-analysis.
Iran J Basic Med Sci. 2021 Jun;24(6):720-725. doi: 10.22038/ijbms.2021.47360.10901.
7
Association between tobacco smoking and drug-resistant tuberculosis.
Infect Drug Resist. 2018 Jun 12;11:873-887. doi: 10.2147/IDR.S164596. eCollection 2018.

本文引用的文献

1
Prevalence and risk factors of drug-resistant tuberculosis in border provinces of Iran.
Postgrad Med. 2015 Aug;127(6):600-6. doi: 10.1080/00325481.2015.1069168. Epub 2015 Jul 15.
2
Risk factors of multidrug resistant tuberculosis in central Nepal: a pilot study.
Kathmandu Univ Med J (KUMJ). 2010 Oct-Dec;8(32):392-7. doi: 10.3126/kumj.v8i4.6238.
4
Drug resistance patterns in pulmonary tuberculosis.
J Pak Med Assoc. 2011 Mar;61(3):229-32.
7
8
Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level.
Eur Respir J. 2009 Nov;34(5):1202-3. doi: 10.1183/09031936.00081909.
10
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验